Doximity, Inc. (DOCS)
| Market Cap | 4.45B -70.1% |
| Revenue (ttm) | 637.78M +15.9% |
| Net Income | 239.40M +18.9% |
| EPS | 1.19 +18.9% |
| Shares Out | 184.71M |
| PE Ratio | 20.23 |
| Forward PE | 15.54 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,940,303 |
| Open | 23.74 |
| Previous Close | 23.76 |
| Day's Range | 23.66 - 24.29 |
| 52-Week Range | 23.58 - 76.51 |
| Beta | 1.39 |
| Analysts | Buy |
| Price Target | 52.26 (+117.12%) |
| Earnings Date | Feb 5, 2026 |
About DOCS
Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, ... [Read more]
Financial Performance
In fiscal year 2025, Doximity's revenue was $570.40 million, an increase of 19.98% compared to the previous year's $475.42 million. Earnings were $223.19 million, an increase of 51.23%.
Financial StatementsAnalyst Summary
According to 19 analysts, the average rating for DOCS stock is "Buy." The 12-month stock price target is $52.26, which is an increase of 117.12% from the latest price.
News
Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights
Shareholders should contact the firm immediately as there may be limited time to enforce your rights Shareholders should contact the firm immediately as there may be limited time to enforce your right...
Doximity: Growth Outlook Is Murky
Doximity remains a Hold as growth visibility weakens and NRR declines to 112%, raising concerns over future expansion. Engagement and profitability are robust, with workflow tools reaching 720,000 uni...
Doximity, Inc. (DOCS) Q3 2026 Earnings Call Transcript
Doximity, Inc. (DOCS) Q3 2026 Earnings Call Transcript
Doximity Stock Is Collapsing After Hours: Here's Why
Doximity, which operates an online networking service for medical professionals, reported third-quarter revenue of $185.05 million, beating estimates of $182.20 million, according to Benzinga Pro. Rev...
Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fifth Consecutive Year
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, announced today that Doximity Dialer has been named the #1 Telehealth Video Co...
Doximity Announces Fiscal 2026 Third Quarter Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 third quarter ended December 31, 20...
Doximity to Release Fiscal 2026 Third Quarter Results on February 5, 2026
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter e...
HALPER SADEH LLC ENCOURAGES DOXIMITY INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Dec. 24, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is inves...
Doximity: Elite Margins, AI Growth, And An Attractive Multiple
Doximity's Q2 results show record engagement and accelerating adoption of AI workflow tools, signaling deeper physician reliance on the platform. Revenue quality is improving as pharma clients shift f...
Doximity, Inc. (DOCS) Q2 2026 Earnings Call Transcript
Doximity, Inc. ( DOCS) Q2 2026 Earnings Call November 6, 2025 5:00 PM EST Company Participants Perry Gold - Head of Investor Relations Jeffrey Tangney - Co-Founder, CEO & Chairperson Anna Bryson - Ch...
Doximity Announces Fiscal 2026 Second Quarter Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 second quarter ended September 30, ...
Doximity to Release Fiscal 2026 Second Quarter Results on November 6, 2025
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ...
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by certain officers and di...
Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings
Doximity Inc DOCS reported better-than-expected earnings for the first quarter on Thursday.
Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript
Doximity, Inc. (NYSE:DOCS) Q1 2026 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Anna Bryson - Chief Financial Officer Jeffrey A. Tangney - Co-Founder, CEO & Chairperson Per...
Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers
Doximity has acquired the AI startup Pathway Medical for $63 million. Pathway has one of the largest structured datasets in medicine, Doximity said.
Doximity Acquires Pathway, a Leader in AI Clinical Reference
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based st...
Doximity Announces Fiscal 2026 First Quarter Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 first quarter ended June 30, 2025. ...
New Doximity Study Shows Modest Physician Pay Growth Amid Deeper Workforce Strain, Reimbursement Pressures
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its 2025 Physician Compensation Report. The findings highlight ...
Doximity: Slowing Sales And EBITDA Growth
Doximity shares have dropped nearly 25% from February highs, despite strong Q4 earnings and 17% revenue growth year-over-year. Analyst sentiment is mixed, and insider selling has notably increased in ...
Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter e...
Doximity Crushes The Rule Of 40 - Try Rule Of 58
I have a price target of $85 for Doximity by summer 2026. There is lots to be bullish about. Doximity's fundamentals are strong: zero debt, a large cash cushion, and robust free cash flow generation s...
Doximity: A Unique, Debt-Free Healthcare-Tech Platform, Initiate With 'Buy'
I rate Doximity a 'Buy' with a $62 fair value, citing its dominant network among U.S. healthcare professionals and robust growth trajectory. Doximity's strong pharma marketing business, workflow solut...
Doximity to Present at the William Blair 45th Annual Growth Stock Conference
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Jeff Tangney, co-founder and CEO, will present at the Wil...
Doximity Stock 7.8% Higher After Key Trading Signal
DOCS reverses steep decline after TradePulse Alert